SCHEMBL6300772

SCHEMBL6300772

CC(C)(O)CON1C(C)(C)CC(OC(=O)NCCCCCCNC(=O)OC2CC(C)(C)N(OCC(C)(C)O)C(C)(C)C2)CC1(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.35
GAA P10253 1/20 0.35
SGPL1 O95470 1/20 0.33
EPHX1 P07099 1/20 0.33
HDAC8 Q9BY41 3/20 0.32
EPHX2 P34913 3/20 0.32
BCHE P06276 1/20 0.32
MAOA P21397 1/20 0.32
MAOB P27338 1/20 0.32
MAN2B1 O00754 1/20 0.32
TSHR P16473 2/20 0.32
KMT2A Q03164 2/20 0.32
HPGD P15428 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
LMNA P02545 1/20 0.31
ACHE P22303 2/20 0.31
MEN1 O00255 1/20 0.31
FAAH O00519 1/20 0.31
ABHD16A O95870 1/20 0.31
PLA2G7 Q13093 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6300796 0.90 DRD2 (0.32) GAASGPL1MAN2B1KMT2AMEN1
SCHEMBL524344 0.82 NAAA (0.39) GAAEPHX2TSHRKMT2ASMN1; SMN2
SCHEMBL21582136 0.82 NAAA (0.39) GAAEPHX2TSHRKMT2ASMN1; SMN2
SCHEMBL3957275 0.81 EPHX2 (0.39) GAAEPHX1EPHX2TSHRKMT2A
SCHEMBL12227670 0.81 TSHR (0.47) GAATSHRKMT2AMEN1
SCHEMBL38998 0.80 KMT2A (0.38) GAAEPHX2TSHRKMT2ASMN1; SMN2
SCHEMBL9400326 0.80 TSHR (0.50) GAASGPL1EPHX1EPHX2BCHE
SCHEMBL39302 0.80 KMT2A (0.38) GAATSHRKMT2ASMN1; SMN2MEN1
SCHEMBL12020715 0.80 TSHR (0.35) GAATSHRKMT2AMEN1
SCHEMBL39577 0.80 KMT2A (0.35) GAATSHRKMT2ASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6391949-B1 None US disclosed
US-6872832-B2 Hydroxy substituted N-alkoxy hindered amines and compositions stabilized therewith CIBA SPECIALTY CHEMICALS CORPORATION (US) 2005-03-29 US disclosed
US-20030120077-A1 Hydroxy substituted N-alkoxy hindered amines and compositions stabilized therewith GALBO JAMES PETER (US) 2003-06-26 US disclosed
US-6420562-B2 OXIDATION, HEAT AND RADIATION RESISTANCE CIBA SPECIALITY CHEMICALS CORPORATION 2002-07-16 US disclosed
US-6403681-B2 STABILIZER FOR PLASTICS CIBA SPECIALTY CHEMICALS CORPORATION 2002-06-11 US disclosed
US-6392041-B1 OXIDATION, HEAT AND RADIATION RESISTANCE CIBA SPECIALTY CHEMICALS CORPORATION 2002-05-21 US disclosed
US-6391949-B2 FOR AUTOMOBILE FINISHES; HEAT, OXIDATION, RADIATION RESISTANCE CIBA SPECIALTY CHEMICALS CORPORATION 2002-05-21 US disclosed
US-20020058735-A1 Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith GALBO JAMES PETER (US) 2002-05-16 US disclosed
US-20010034449-A1 Hydroxy-substituted N-Alkoxy hindered amines and compositions stabilized therewith GALBO JAMES P (US) 2001-10-25 US disclosed
US-20010031872-A1 Hydroxy-substituted N-Alkoxy hindered amines and compositions stabilized therewith GALBO JAMES P (US) 2001-10-18 US disclosed
US-20010018520-A1 Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith GALBO JAMES P (US) 2001-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020058735-A1 Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith OGG1, HAO2, POLH TDP1 663/4885GAA 1255/4885SGPL1 4265/4885
US-20010034449-A1 Hydroxy-substituted N-Alkoxy hindered amines and compositions stabilized therewith POLH, OGG1, OGFOD1 TDP1 606/4885GAA 1582/4885SGPL1 4303/4885
US-20030120077-A1 Hydroxy substituted N-alkoxy hindered amines and compositions stabilized therewith OGG1, POLH, OGFOD1 TDP1 688/4885GAA 1590/4885SGPL1 4281/4885
US-20010018520-A1 Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith POLH, OGG1, OGFOD1 TDP1 606/4885GAA 1582/4885SGPL1 4303/4885
US-20010031872-A1 Hydroxy-substituted N-Alkoxy hindered amines and compositions stabilized therewith POLH, OGG1, OGFOD1 TDP1 606/4885GAA 1582/4885SGPL1 4303/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.